Intensive insulin therapy in the ICU-reconciling the evidence

Nature Reviews Endocrinology

Volumn 8, Issue 6, 2012, Pages 374-378

  Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

BLOOD GLUCOSE MONITORING; CRITICAL ILLNESS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; MACRONUTRIENT; NUTRIENT; PARENTERAL NUTRITION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

BLOOD GLUCOSE; CRITICAL ILLNESS; EVIDENCE-BASED MEDICINE; HUMANS; HYPERGLYCEMIA; INSULIN; INTENSIVE CARE UNITS; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84861331822     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2012.14     Document Type: Review

References (46)

1. Van den Berghe, G. et al. Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J. Clin. Endocrinol. Metab. 94, 3163-3170 (2009).
2. Kosiborod, M. et al. Glucose normalization and outcomes in patients with acute myocardial infarction. Arch. Intern. Med. 169, 438-446 (2009).
3. The Endocrine Society. The Endocrine Society statement to providers on the American College of Physicians guidelines on intensive insulin therapy [online], http://www.endo-society.org/advocacy/insider/2011/upload/TES- Statement-about-ACP-Guidelines-23-FEB-11-2.pdf (2011).
4. American Diabetes Association. Executive summary: standards of medical care in diabetes-2011. Diabetes Care 34 (Suppl 1.), S4-S10 (2011).
5. Qaseem, A., Humphrey, L. L., Chou, R., Snow, V. & Shekelle, P. Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 154, 260-267 (2011).
6. Dellinger, R. P. et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 36, 296-327 (2008).
7. Erratum in: Crit. Care Med. 36, 1394-1396 (2008).
8. Skyler, J. S. et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J. Am. Coll. Cardiol. 53, 298-304 (2009).
9. Van den Berghe, G. et al. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345, 1359-1367 (2001).
10. Kreymann, K. G. et al. ESPEN guidelines on enteral nutrition: intensive care. Clin. Nutr. 25, 210-223 (2006). (Pubitemid 43811686)
11. Singer, P. et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin. Nutr. 28, 387-400 (2009).
12. Van den Berghe, G. et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit. Care Med. 31, 359-366 (2003). (Pubitemid 36232926)
13. Van den Berghe, G. et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55, 3151-3159 (2006). (Pubitemid 44923655)
14. Ellger, B. et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycaemia versus glycemia-independent actions of insulin. Diabetes 55, 1096-1105 (2006). (Pubitemid 44100187)
15. Van den Berghe, G. et al. Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 354, 449-461 (2006). (Pubitemid 43200296)
16. Schetz, M., Vanhorebeek, I., Wouters, P. J., Wilmer, A. & Van den Berghe, G. Tight blood glucose control is renoprotective in critically ill patients. J. Am. Soc. Nephrol. 19, 571-578 (2008). (Pubitemid 351355400)
17. Vlasselaers, D. et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomized controlled study. Lancet 373, 547-556 (2009).
18. Furnary, A. P., Cheek, D. B., Holmes, S. C., Howell, W. L. & Kelly, S. P. Achieving tight glycemic control in the operating room: lessons learned from 12 years in the trenches of a paradigm shift in anesthetic care. Semin. Thorac. Cardiovasc. Surg. 18, 339-345 (2006). (Pubitemid 46464519)
19. Krinsley, J. S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin. Proc. 79, 992-1000 (2004). (Pubitemid 39007018)
20. Erratum in: Mayo Clin. Proc. 80, 1101 (2005).
21. Reed, C. C. et al. Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J. Am. Coll. Surg. 204, 1048-1054; discussion 1054-1055 (2007). (Pubitemid 46661216)
22. Lecomte, P. et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Crit. Care 12, R154 (2008).
23. Finfer, S. et al. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 360, 1283-1297 (2009).
24. Scott, M. G., Bruns, D. E., Boyd, J. C. & Sacks, D. B. Tight glucose control in the intensive care unit: are glucose meters up to the task? Clin. Chem. 55, 18-20 (2009).
25. Vlasselaers, D. et al. Blood glucose measurements in arterial blood of intensive care unit patients submitted to tight glycemic control: agreement between bedside tests. J. Diabetes Sci. Technol. 2, 932-938 (2008).
26. Egi, M., Finfer, S. & Bellomo, R. Glycemic control in the ICU. Chest 140, 212-220 (2011).
27. Cembrowski, G. S. et al. Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial? Clin. Chem. 56, 1193-1195 (2010).
28. Boyd, J. C. & Bruns, D. E. Monte Carlo simulation in establishing analytical requirements for clinical laboratory tests: meeting the clinical needs. Methods Enzymol. 467, 411-433 (2009).
29. Karon, B. S., Boyd, J. C. & Klee, G. G. Glucose meter performance criteria for tight glycemic control estimated by simulation modeling. Clin. Chem. 56, 1091-1097 (2010).
30. Kanji, S. et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit. Care Med. 33, 2778-2785 (2005). (Pubitemid 41816412)
31. Villet, S. et al. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin. Nutr. 24, 502-509 (2005). (Pubitemid 41051903)
32. Martindale, R. G. et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit. Care Med. 37, 1757-1761 (2009).
33. Heyland, D. K., Dhaliwal, R., Drover, J. W., Gramlich, L. & Dodek, P. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. J. Parenter. Enteral. Nutr. 27, 355-373 (2003). (Pubitemid 37022781)
34. Reid, C. Frequency of under-and overfeeding in mechanically ventilated ICU patients: causes and possible consequences. J. Hum. Nutr. Diet. 19, 13-22 (2006).
35. Dhaliwal, R., Jurewitsch, B., Harrietha, D. & Heyland, D. K. Combination enteral and parenteral nutrition in critically ill patients: harmful or beneficial? A systematic review of the evidence. Intensive Care Med. 30, 1666-1671 (2004). (Pubitemid 39094972)
36. Casaer, M. P. et al. Early versus late parenteral nutrition in critically ill adults. N. Engl. J. Med. 365, 506-517 (2011).
37. Vanhorebeek, I. et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365, 53-59 (2005). (Pubitemid 40082146)
38. Langouche, L. et al. Intensive insulin therapy protects the endothelium of critically ill patients. J. Clin. Invest. 115, 2277-2286 (2005). (Pubitemid 41134169)
39. Van den Berghe, G., Schoonheydt, K., Becx, P., Bruyninckx, F. & Wouters, P. J. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64, 1348-1353 (2005). (Pubitemid 40570499)
40. Vanhorebeek, I. et al. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Crit. Care Med. 37, 1355-1364 (2009).
41. Vanhorebeek, I. et al. Hyperglycemic kidney damage in an animal model of prolonged critical illness. Kidney Int. 76, 512-520 (2009).
42. Van den Berghe, G. How does blood glucose control with insulin save lives in intensive care? J. Clin. Invest. 114, 1187-1195 (2004). (Pubitemid 40385286)
43. Langouche, L. et al. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J. Clin. Endocrinol. Metab. 92, 3890-3897 (2007). (Pubitemid 47607638)
44. Vanhorebeek, I. et al. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients. J. Clin. Endocrinol. Metab. 96, E633-E645 (2011).
45. Rabinowitz, J. D. & White, E. Autophagy and metabolism. Science 330, 1344-1348 (2010).
46. Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 27-42 (2008).